Analystreport

Celyad Oncology SA (NASDAQ: CYAD) had its price target raised by analysts at Wells Fargo & Company from $11.00 to $20.00.

Celyad Oncology SA - American Depositary Shares  (CYAD) 
US:NASDAQ Investor Relations: celyad.com/en/investors